PhysicianIndustry Relations. Part 1: Individual Physicians

@article{Coyle2002PhysicianIndustryRP,
  title={PhysicianIndustry Relations. Part 1: Individual Physicians},
  author={Susan L. Coyle},
  journal={Annals of Internal Medicine},
  year={2002},
  volume={136},
  pages={396-402}
}
  • S. Coyle
  • Published 5 March 2002
  • Medicine
  • Annals of Internal Medicine
In 1990, the American College of Physicians published a position statement titled Physicians and the Pharmaceutical Industry to address ethical issues in relationships between industry and the medical profession (1). The statement, which was prompted in large part by evidence of the drug industry's influence on physician behavior and concern for professional integrity and patient care, examined potential conflicts of interest in relationships with industry and provided ethical advice in certain… Expand
PhysicianIndustry Relations
TLDR
A revision to position 1 (Industry Gifts, Hospitality, Services, and Subsidies) of the ACP position paper on physicianindustry relations is approved, including moving some language from the rationale directly into the position. Expand
In Defense of Industry-Physician Relationships
TLDR
The objective was to examine the economic, ethical, and legal foundations for conflict of interest restrictions between physicians and pharmaceutical and medical device industries and determine whether excellent service to patients may be a more realistic standard. Expand
One resident perspective: resident education and the pharmaceutical industry.
  • C. Grudzen
  • Medicine
  • Annals of emergency medicine
  • 2005
TLDR
Although pharmaceutical company support of physicians once went almost unchecked, there has been a movement toward limiting the industry’s contact with physicians. Expand
Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
BACKGROUND Personalized pharmaceutical marketing to physicians, including the provision of gifts and sponsorship of educational and recreational activities, raises ethical issues. We sought toExpand
Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia.
TLDR
The findings suggest that in developing normative guidelines for academic and professional practice, policy makers should recognise and account for the complexity of the relationship and for the variation in medical specialists' views and feelings. Expand
Financial disclosure, industry sponsorship, and integrity in cancer research reporting.
  • D. Johnson
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2013
TLDR
A study to “identify whether there was any association between conclusions of authors of editorials and related phase III trials and self-reported COI or sponsorship” in recently published cancer studies found that the trial results and the authors’ conclusions were congruent. Expand
Pharmaceutical industry sponsorship of academic conferences: ethics of conflict of interest
  • S. Jayasinghe
  • Medicine, Political Science
  • Journal of Medical Ethics
  • 2020
TLDR
Establishing clear rules of engagement between the stakeholders should be considered as an attempt to clear the muddy waters, and a set of guidelines to capture these approaches are proposed. Expand
Understanding physician-pharmaceutical industry interactions
TLDR
This work discusses physician-pharmaceutical industry interactions, the law, and the media, and investigates the use of pharmaceutical industry-supplied medications in medical practice and patient perceptions of physicians' acceptance of gifts from the pharmaceutical industry. Expand
Interactions between emergency medicine programs and the pharmaceutical industry.
  • S. Keim, M. Mays, D. Grant
  • Medicine
  • Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
  • 2004
TLDR
A wide range of practices exist among emergency medicine residency program directors, and most desire organizational guidelines regarding interactions with the pharmaceutical industry. Expand
Gifts to physicians from industry: the debate evolves.
TLDR
The history of professional attention to gift giving is outlined and recent contributions to the ongoing debate over its justifiability are reviewed, including professional association recommendations for limitation or prohibition of the practice. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 59 REFERENCES
Physicians and the pharmaceutical industry. American College of Physicians.
TLDR
This position paper addresses controversial issues related to the ethics of physician encounters with industry and identifies certain areas where specific guidance may be provided to supplement continued reliance on individual physician judgment. Expand
The relationship between physicians in training and pharmaceutical companies. A time for guidelines?
  • D. Girard
  • Medicine
  • Archives of internal medicine
  • 1992
TLDR
The time has come to establish guidelines to protect the social contract that physicians have with their patients, and the relationships between physicians in training and pharmaceutical companies should be examined. Expand
Physicians and the pharmaceutical industry: is a gift ever just a gift?
TLDR
The present extent of physician-industry interactions appears to affect prescribing and professional behavior and should be further addressed at the level of policy and education. Expand
Attitudes of medical school faculty toward gifts from the pharmaceutical industry
  • J. Banks, A. Mainous
  • Medicine
  • Academic medicine : journal of the Association of American Medical Colleges
  • 1992
TLDR
Both the ethical considerations and the utility of guidelines for physician- industry interactions are discussed, with a majority of the faculty believed that personal relationships had the potential to influence prescribing patterns but that gifts, in general, did not greatly influence prescribing behaviors. Expand
Doctors, drug companies, and gifts.
TLDR
It is concluded that accepting a gift has complex practical and ethical repercussions and the need for guidelines for the profession to help physicians promote their patients' well-being is discussed. Expand
Interactions between physicians and the pharmaceutical industry: what does the literature say?
  • J. Lexchin
  • Medicine
  • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 1993
TLDR
The CMA's guidelines on this topic should be evaluated to see whether they are effective in controlling physician-industry interactions and further measures may be necessary if the guidelines fail to prevent negative effects on prescribing practices. Expand
Patient perceptions of physician acceptance of gifts from the pharmaceutical industry.
TLDR
The results suggest that the public is generally uninformed about personal gifts from pharmaceutical companies to physicians, and a reevaluation may be in order for guidelines regarding physician acceptance of gifts from the pharmaceutical industry. Expand
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
TLDR
To study the relative contributions of scientific and commercial sources of information, two index drugs were chosen, whose pharmacologic effects have been shown by controlled studies to be minimal or not significantly different from those of nonprescription (over-thecounter) preparations, but which are heavily advertised as being effective. Expand
Separating continuing medical education from pharmaceutical marketing.
TLDR
Evidence is shown that industry-supported educational activities are slanted in favor of the financial supporter’s products and that physicians attending such courses later prescribe these products more often than competing drugs. Expand
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.
TLDR
Requests by physicians that drugs be added to a hospital formulary were strongly and specifically associated with the physicians' interactions with the companies manufacturing the drugs. Expand
...
1
2
3
4
5
...